- Clinical Trials
- April 2024
- 50 Pages
Global
From €1026EUR$1,050USD£856GBP
€1466EUR$1,500USD£1,224GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €855EUR$875USD£714GBP
€1221EUR$1,250USD£1,020GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1368EUR$1,400USD£1,142GBP
€1954EUR$2,000USD£1,631GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1368EUR$1,400USD£1,142GBP
€1954EUR$2,000USD£1,631GBP
- Drug Pipelines
- February 2024
- 60 Pages
Global
From €1026EUR$1,050USD£856GBP
€1466EUR$1,500USD£1,224GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €855EUR$875USD£714GBP
€1221EUR$1,250USD£1,020GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €855EUR$875USD£714GBP
€1221EUR$1,250USD£1,020GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €855EUR$875USD£714GBP
€1221EUR$1,250USD£1,020GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1368EUR$1,400USD£1,142GBP
€1954EUR$2,000USD£1,631GBP
- Report
- January 2024
- 172 Pages
Global
From €2443EUR$2,500USD£2,039GBP
- Report
- January 2024
- 171 Pages
Global
From €2443EUR$2,500USD£2,039GBP
- Report
- May 2024
- 200 Pages
Global
From €4055EUR$4,150USD£3,385GBP
- Report
- February 2024
- 140 Pages
Global
From €5373EUR$5,499USD£4,485GBP
- Report
- March 2024
- 200 Pages
Global
From €4055EUR$4,150USD£3,385GBP
- Report
- March 2024
- 200 Pages
Global
From €4055EUR$4,150USD£3,385GBP
- Report
- August 2024
- 240 Pages
Global
From €4884EUR$4,999USD£4,078GBP
- Report
- November 2024
- 50 Pages
Global
From €2589EUR$2,650USD£2,162GBP
- Report
- February 2024
- 30 Pages
United States
€1539EUR$1,575USD£1,285GBP
€2198EUR$2,250USD£1,835GBP
- Report
- July 2021
Global
From €927EUR$949USD£774GBP
- Report
- November 2024
Global
From €400EUR$439USD£346GBP
The Immunosuppressive Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that suppress the immune system. These drugs are used to treat autoimmune diseases, organ transplant rejection, and other conditions where the immune system is overactive. Immunosuppressive drugs work by blocking the action of certain cells in the immune system, preventing them from attacking healthy tissue.
Immunosuppressive drugs are typically administered orally or intravenously, and can be used in combination with other treatments such as steroids or chemotherapy. Common side effects of immunosuppressive drugs include nausea, vomiting, diarrhea, and increased risk of infection.
Some of the major companies in the Immunosuppressive Drugs market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more